Zinc delivery from non-woven fibres within a therapeutic nipple shield

Theresa Maier, Rebekah L. Scheuerle, Daniel Markl, Sylvaine Bruggraber, Axel Zeitler, Ljiljana Fruk, Nigel K.H. Slater

Research output: Contribution to journalArticle

2 Citations (Scopus)
11 Downloads (Pure)

Abstract

A Therapeutic Nipple Shield (TNS) was previously developed to respond to the global need for new infant therapeutic delivery technologies. However, the release efficiency for the same Active Pharmaceutical Ingredient (API) from different therapeutic matrices within the TNS formulation has not yet been investigated. To address this, in-vitro release of elemental zinc into human milk from two types of Texel non-woven fibre mats of varying thickness and different gram per square meter values, placed inside the TNS was explored and compared to the release from zinc-containing rapidly disintegrating tablets. In-vitro delivery was performed by means of a breastfeeding simulation apparatus, with human milk flow rates and suction pressure adjusted to physiologically relevant values, and release was quantified using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). It was found that a total recovery of 62–64 % elemental zinc was obtained after the human milk had passed through the fibre insert, amounting to a 20–48% increase compared to previous zinc delivery studies using rapidly disintegrating tablets within the TNS. This indicates that non-woven Texel fibre mats were identified as the superior dosage form for oral zinc delivery into human milk using a TNS.

Original languageEnglish
Pages (from-to)290-299
Number of pages10
JournalInternational Journal of Pharmaceutics
Volume537
Issue number1-2
Early online date27 Dec 2017
DOIs
Publication statusPublished - 15 Feb 2018

Fingerprint

Nipples
Zinc
Human Milk
Therapeutics
Tablets
Dosage Forms
Suction
Breast Feeding
Spectrum Analysis
Technology
Pressure
Pharmaceutical Preparations

Keywords

  • breastfeeding
  • human milk
  • medication systems
  • oral delivery
  • pediatrics
  • X-ray micro computed tomography

Cite this

Maier, T., Scheuerle, R. L., Markl, D., Bruggraber, S., Zeitler, A., Fruk, L., & Slater, N. K. H. (2018). Zinc delivery from non-woven fibres within a therapeutic nipple shield. International Journal of Pharmaceutics, 537(1-2), 290-299. https://doi.org/10.1016/j.ijpharm.2017.12.042
Maier, Theresa ; Scheuerle, Rebekah L. ; Markl, Daniel ; Bruggraber, Sylvaine ; Zeitler, Axel ; Fruk, Ljiljana ; Slater, Nigel K.H. / Zinc delivery from non-woven fibres within a therapeutic nipple shield. In: International Journal of Pharmaceutics. 2018 ; Vol. 537, No. 1-2. pp. 290-299.
@article{553868446bc54b39b5089c9c1d11a0df,
title = "Zinc delivery from non-woven fibres within a therapeutic nipple shield",
abstract = "A Therapeutic Nipple Shield (TNS) was previously developed to respond to the global need for new infant therapeutic delivery technologies. However, the release efficiency for the same Active Pharmaceutical Ingredient (API) from different therapeutic matrices within the TNS formulation has not yet been investigated. To address this, in-vitro release of elemental zinc into human milk from two types of Texel non-woven fibre mats of varying thickness and different gram per square meter values, placed inside the TNS was explored and compared to the release from zinc-containing rapidly disintegrating tablets. In-vitro delivery was performed by means of a breastfeeding simulation apparatus, with human milk flow rates and suction pressure adjusted to physiologically relevant values, and release was quantified using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). It was found that a total recovery of 62–64 {\%} elemental zinc was obtained after the human milk had passed through the fibre insert, amounting to a 20–48{\%} increase compared to previous zinc delivery studies using rapidly disintegrating tablets within the TNS. This indicates that non-woven Texel fibre mats were identified as the superior dosage form for oral zinc delivery into human milk using a TNS.",
keywords = "breastfeeding, human milk, medication systems, oral delivery, pediatrics, X-ray micro computed tomography",
author = "Theresa Maier and Scheuerle, {Rebekah L.} and Daniel Markl and Sylvaine Bruggraber and Axel Zeitler and Ljiljana Fruk and Slater, {Nigel K.H.}",
year = "2018",
month = "2",
day = "15",
doi = "10.1016/j.ijpharm.2017.12.042",
language = "English",
volume = "537",
pages = "290--299",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
number = "1-2",

}

Maier, T, Scheuerle, RL, Markl, D, Bruggraber, S, Zeitler, A, Fruk, L & Slater, NKH 2018, 'Zinc delivery from non-woven fibres within a therapeutic nipple shield', International Journal of Pharmaceutics, vol. 537, no. 1-2, pp. 290-299. https://doi.org/10.1016/j.ijpharm.2017.12.042

Zinc delivery from non-woven fibres within a therapeutic nipple shield. / Maier, Theresa; Scheuerle, Rebekah L.; Markl, Daniel; Bruggraber, Sylvaine; Zeitler, Axel; Fruk, Ljiljana; Slater, Nigel K.H.

In: International Journal of Pharmaceutics, Vol. 537, No. 1-2, 15.02.2018, p. 290-299.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Zinc delivery from non-woven fibres within a therapeutic nipple shield

AU - Maier, Theresa

AU - Scheuerle, Rebekah L.

AU - Markl, Daniel

AU - Bruggraber, Sylvaine

AU - Zeitler, Axel

AU - Fruk, Ljiljana

AU - Slater, Nigel K.H.

PY - 2018/2/15

Y1 - 2018/2/15

N2 - A Therapeutic Nipple Shield (TNS) was previously developed to respond to the global need for new infant therapeutic delivery technologies. However, the release efficiency for the same Active Pharmaceutical Ingredient (API) from different therapeutic matrices within the TNS formulation has not yet been investigated. To address this, in-vitro release of elemental zinc into human milk from two types of Texel non-woven fibre mats of varying thickness and different gram per square meter values, placed inside the TNS was explored and compared to the release from zinc-containing rapidly disintegrating tablets. In-vitro delivery was performed by means of a breastfeeding simulation apparatus, with human milk flow rates and suction pressure adjusted to physiologically relevant values, and release was quantified using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). It was found that a total recovery of 62–64 % elemental zinc was obtained after the human milk had passed through the fibre insert, amounting to a 20–48% increase compared to previous zinc delivery studies using rapidly disintegrating tablets within the TNS. This indicates that non-woven Texel fibre mats were identified as the superior dosage form for oral zinc delivery into human milk using a TNS.

AB - A Therapeutic Nipple Shield (TNS) was previously developed to respond to the global need for new infant therapeutic delivery technologies. However, the release efficiency for the same Active Pharmaceutical Ingredient (API) from different therapeutic matrices within the TNS formulation has not yet been investigated. To address this, in-vitro release of elemental zinc into human milk from two types of Texel non-woven fibre mats of varying thickness and different gram per square meter values, placed inside the TNS was explored and compared to the release from zinc-containing rapidly disintegrating tablets. In-vitro delivery was performed by means of a breastfeeding simulation apparatus, with human milk flow rates and suction pressure adjusted to physiologically relevant values, and release was quantified using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). It was found that a total recovery of 62–64 % elemental zinc was obtained after the human milk had passed through the fibre insert, amounting to a 20–48% increase compared to previous zinc delivery studies using rapidly disintegrating tablets within the TNS. This indicates that non-woven Texel fibre mats were identified as the superior dosage form for oral zinc delivery into human milk using a TNS.

KW - breastfeeding

KW - human milk

KW - medication systems

KW - oral delivery

KW - pediatrics

KW - X-ray micro computed tomography

UR - http://www.scopus.com/inward/record.url?scp=85044368685&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2017.12.042

DO - 10.1016/j.ijpharm.2017.12.042

M3 - Article

VL - 537

SP - 290

EP - 299

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -